Partner Content
How CATs can enhance clinical trials
PROMs are composed of a fixed number of items – that is, a question and its associated response scale. While…
Outsourcing trends in clinical trials: How one company is reimagining the FSP model
Full-service outsourcing has traditionally ruled the roost in the clinical world, but increased competition from functional service providers (FSPs) has…
Host-Cell Protein Analytics: History and Future Trends
Different analytical methods have been developed to detect host-cell proteins (HCPs) in bioprocess streams. Advancements in such methods are enabling…
No more cookies: How healthcare companies can gain trust for data consent
Data is a valuable commodity in an age of data-driven marketing, but considerable care must be taken when collecting sensitive…
Improving health equity in Europe’s small countries: How can we remove the barriers to access?
When it comes to health equity, the citizens of smaller countries in Europe can sometimes be at a disadvantage. According…
Launching pharmaceuticals in the Nordics: Opportunities and challenges
The Nordic countries have it all. From beautiful landscapes lit by the northern lights to world-class living standards and generous…
Clinical trials: How AI can help providers stay TMF inspection-ready
The clinical trials landscape is evolving quickly. Delivery of clinical research has changed as the industry has faced myriad challenges,…
Does AI/ML make CROs obsolete? It depends…
One of the many luxuries of working in an industry for a long time is that you get to witness…
How a flexible FSP model fills the talent gap
There is continuous evaluation and varying opinion regarding the strategic resourcing models employed within the biopharmaceutical sector today. Notwithstanding the…
New US serialization requirements: how will they impact the pharma supply chain?
First introduced in 2013 under The Drug Supply Chain Security Act (DSCSA), serialization aims to enable more effective traceability of…